Can a smartphone qigong program heal the mental toll of COVID-19?
NCT ID NCT06194357
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests a 16-week program that combines mindfulness with gentle qigong exercises, delivered through a mobile app. It aims to reduce stress, depression, and anxiety in COVID-19 survivors, their caregivers, and the general public. Participants are randomly assigned to either the program or standard care, and their well-being is tracked over a year. The goal is to see if this mind-body practice can improve both mental and physical health after a pandemic.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mindfulness-based Health Qigong Intervention
- What this could lead to
- If effective, this program could offer a low-cost, accessible way to ease lingering stress, anxiety, and depression after COVID-19.
- What could go wrong
- This is an early-stage study comparing the program to usual care, so results may not show a clear benefit. The intervention requires consistent self-practice, which may be hard for some participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Hospital
Hong Kong, Hong Kong
-
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI analyzes 100,000 COVID-19 cases to predict who gets worst outcomes
- New ibuzatrelvir tablet put to the test in healthy volunteers
- New vaccine aims to shield leukemia patients from COVID-19
- Cancer Patients' pandemic struggles revealed in new study
- Survey reveals how pandemic reshaped lung care
- New vaccine aims to better protect blood cancer patients from COVID-19